Cargando…

Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome

BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Östlund Papadogeorgos, Nikolaos, Jörneskog, Gun, Bengtsson, Mattias, Kahan, Thomas, Kalani, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837627/ https://www.ncbi.nlm.nih.gov/pubmed/27095564 http://dx.doi.org/10.1186/s12933-016-0385-6

Ejemplares similares

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
por: Östlund Papadogeorgos, Nikolaos, et al.
Publicado: (2009)

Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia
por: Kuhl, Jeanette, et al.
Publicado: (2015)

Skin microvascular reactivity correlates to clinical microangiopathy in type 1 diabetes: A pilot study
por: Tehrani, Sara, et al.
Publicado: (2020)

Improved Peripheral Perfusion During Endothelin-A Receptor Blockade in Patients With Type 2 Diabetes and Critical Limb Ischemia
por: Kalani, Majid, et al.
Publicado: (2008)

The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin–ramipril study
por: Jekell, Andreas, et al.
Publicado: (2018)

The importance of endothelin-1 for microvascular dysfunction in diabetes
por: Kalani, Majid
Publicado: (2008)

Changes in Index of Microcirculatory Resistance during PCI in the Left Anterior Descending Coronary Artery in Relation to Total Length of Implanted Stents
por: Ekenbäck, Christina, et al.
Publicado: (2019)

Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes
por: Torffvit, Ole, et al.
Publicado: (2012)

Early impairment of coronary microvascular perfusion capacity in rats on a high fat diet
por: van Haare, Judith, et al.
Publicado: (2015)

The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin–ramipril study
por: Jekell, Andreas, et al.
Publicado: (2016)

Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease
por: Sara, Jaskanwal D., et al.
Publicado: (2019)

Genetic predisposition to type 2 diabetes is associated with severity of coronary artery disease in patients with acute coronary syndromes
por: Zheng, Qiwen, et al.
Publicado: (2019)

Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus
por: Kawata, Takayuki, et al.
Publicado: (2015)

Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes
por: Zobel, Emilie H., et al.
Publicado: (2020)

Cyclooxygenase inhibition corrects the impaired microvascular reactivity in diabetic female rats
por: Akamine, EH, et al.
Publicado: (2003)

Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long‐term outcomes in patients with INOCA
por: Mohammed, Ayman A., et al.
Publicado: (2022)

Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes
por: Gurka, Matthew J., et al.
Publicado: (2018)

Distribution and Economic Burden of Diabetes-Related Microvascular Complications in Türkiye
por: Birinci, Şuayıp, et al.
Publicado: (2023)

Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker
por: Pacheco, Christine, et al.
Publicado: (2021)

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
por: Ott, Christian, et al.
Publicado: (2014)

Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet
por: Aoqui, Cristiane, et al.
Publicado: (2014)

Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease
por: Andersson, Charlotte, et al.
Publicado: (2010)

Coronary microvascular dysfunction in diabetes mellitus
por: Kibel, Aleksandar, et al.
Publicado: (2017)

Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)
por: Leibovitz, Eyal, et al.
Publicado: (2013)

Impact of renal function on residual platelet reactivity and clinical outcomes in patients with acute coronary syndrome treated with clopidogrel
por: Li, Qing, et al.
Publicado: (2021)

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob(−/−) mice
por: Adingupu, Damilola D., et al.
Publicado: (2019)

MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes
por: Veitch, Shawn, et al.
Publicado: (2022)

Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of Indigenous cohorts with diabetes in Australia and Canada
por: Maple-Brown, Louise J, et al.
Publicado: (2012)

Inflammation in Coronary Microvascular Dysfunction
por: Sagris, Marios, et al.
Publicado: (2021)

Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes
por: Tong, Guoxin, et al.
Publicado: (2013)

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
por: Faber, Rebekka, et al.
Publicado: (2015)

The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy
por: Hosseini, S. Mohsen, et al.
Publicado: (2014)

Hemodynamic Reactivity to Mental Stress in Patients With Coronary Artery Disease
por: Moazzami, Kasra, et al.
Publicado: (2023)

Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines
por: Kim, Jong-Youn, et al.
Publicado: (2013)

Usefulness of electronic databases for the detection of unrecognized diabetic patients
por: Vinker, Shlomo, et al.
Publicado: (2003)

The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control
por: Casanova, F., et al.
Publicado: (2017)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Quantitative Microvascular Analysis With Wide-Field Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy
por: Tan, Bingyao, et al.
Publicado: (2020)

Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study
por: de Ritter, Rianneke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nseh1k20ta23mpivfogso7deh9